|Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing|
E Heitzer, M Auer, C Gasch, M Pichler, P Ulz, EM Hoffmann, S Lax, ...
Cancer research 73 (10), 2965-2975, 2013
|Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer|
M Stotz, A Gerger, F Eisner, J Szkandera, H Loibner, AL Ress, P Kornprat, ...
British journal of cancer 109 (2), 416-421, 2013
|Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing|
E Heitzer, P Ulz, J Belic, S Gutschi, F Quehenberger, K Fischereder, ...
Genome medicine 5 (4), 1-16, 2013
|Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients|
M Pichler, GC Hutterer, C Stoeckigt, TF Chromecki, T Stojakovic, ...
British journal of cancer 108 (4), 901-907, 2013
|Junk DNA and the long non-coding RNA twist in cancer genetics|
H Ling, K Vincent, M Pichler, R Fodde, I Berindan-Neagoe, FJ Slack, ...
Oncogene 34 (39), 5003-5011, 2015
|Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients|
T Gary, M Pichler, K Belaj, F Hafner, A Gerger, H Froehlich, P Eller, P Rief, ...
PloS one 8 (7), e67688, 2013
|Heterogeneity of Epidermal Growth Factor Receptor Status and Mutations of KRAS/PIK3CA in Circulating Tumor Cells of Patients with Colorectal Cancer|
C Gasch, T Bauernhofer, M Pichler, S Langer-Freitag, M Reeh, AM Seifert, ...
Clinical chemistry 59 (1), 252-260, 2013
|The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer|
M Stotz, M Pichler, G Absenger, J Szkandera, F Arminger, ...
British journal of cancer 110 (2), 435-440, 2014
|The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients|
S Krenn-Pilko, U Langsenlehner, EM Thurner, T Stojakovic, M Pichler, ...
British journal of cancer 110 (10), 2524-2530, 2014
|A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients|
G Absenger, J Szkandera, M Pichler, M Stotz, F Arminger, ...
British journal of cancer 109 (2), 395-400, 2013
|MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients|
M Pichler, GA Calin
British journal of cancer 113 (4), 569-573, 2015
|Establishment of tumor‐specific copy number alterations from plasma DNA of patients with cancer|
E Heitzer, M Auer, EM Hoffmann, M Pichler, C Gasch, P Ulz, S Lax, ...
International journal of cancer 133 (2), 346-356, 2013
|Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing|
S Mohan, E Heitzer, P Ulz, I Lafer, S Lax, M Auer, M Pichler, A Gerger, ...
PLoS Genet 10 (3), e1004271, 2014
|Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients|
J Szkandera, M Stotz, G Absenger, T Stojakovic, H Samonigg, P Kornprat, ...
British journal of cancer 110 (1), 183-188, 2014
|The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas|
J Szkandera, A Gerger, B Liegl‐Atzwanger, G Absenger, M Stotz, ...
International journal of cancer 135 (2), 362-370, 2014
|Epigenetic control of epithelial-mesenchymal-transition in human cancer|
T Kiesslich, M Pichler, D Neureiter
Molecular and clinical oncology 1 (1), 3-11, 2013
|Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients|
J Szkandera, G Absenger, B Liegl-Atzwanger, M Pichler, M Stotz, ...
British journal of cancer 108 (8), 1677-1683, 2013
|Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors|
M Pichler, M Balic, E Stadelmeyer, C Ausch, M Wild, C Guelly, ...
The Journal of Molecular Diagnostics 11 (2), 140-147, 2009
|The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis|
H Ling, K Pickard, C Ivan, C Isella, M Ikuo, R Mitter, R Spizzo, MD Bullock, ...
Gut 65 (6), 977-989, 2016
|Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer|
M Pichler, E Winter, M Stotz, K Eberhard, H Samonigg, S Lax, G Hoefler
British journal of cancer 106 (11), 1826-1832, 2012